ロード中...
Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection
Immune-checkpoint inhibitors (ICPIs), including antibodies against cytotoxic T-lymphocyte associated antigen 4 and programmed cell death protein 1, have been shown to induce durable complete responses in a proportion of patients in the first-line and refractory setting in advanced melanoma and renal...
保存先:
| 出版年: | Ther Adv Med Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6024333/ https://ncbi.nlm.nih.gov/pubmed/29977349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918777427 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|